Investing
Cathie Wood's ARK Invest Buys Over 7 Million Shares of This Biotech-Focused SPAC
Published:
A couple ARK Invest exchange-traded funds run by ETF star Cathie Wood bought over 7 million shares of Soaring Eagle Acquisition Corp. (NASDAQ: SRNG) on Monday, as the share price of these exchange-traded funds were up around 1% in the day’s session. Their share prices have greatly improved over the past year.
Specifically, ARK Genomic Revolution ETF (NYSEARCA: ARKG) bought 4,512,926 shares of the special purpose acquisition company (SPAC), and ARK Innovation ETF (NYSEARCA: ARKK) bought 2,506,461 shares. At Monday’s closing prices, this would have valued this purchase at roughly $70.2 million. This is only a small fraction of the total holdings. ARKG is up 57% over the past 52 weeks and ARKK is up 54%.
Here is a quick look at all the purchases made by ARK ETFs:
Fund | Ticker | Company | Shares |
---|---|---|---|
ARKG | ADPT | Adaptive Biotechnologies | 232,610 |
ARKG | SRNG | Soaring Eagle Acquisition | 4,512,926 |
ARKG | SGFY | Signify Health | 30,490 |
ARKK | Z | Zillow | 101,994 |
ARKK | TSP | TuSimple | 316,814 |
ARKK | SRNG | Soaring Eagle Acquisition | 2,506,461 |
ARKQ | MKFG | Markforged | 57,406 |
ARKQ | PATH | UiPath | 8,178 |
ARKW | LPSN | LivePerson | 22,696 |
ARKW | Z | Zillow | 24,750 |
ARKW | PATH | UiPath | 8,641 |
ARKX | BLDE | Blade Air Mobility | 16,370 |
ARKX | KTOS | Kratos Defense & Security Solutions | 49,634 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
Are you ready for retirement? Planning for retirement can be overwhelming, that’s why it could be a good idea to speak to a fiduciary financial advisor about your goals today.
Start by taking this retirement quiz right here from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes. Smart Asset is now matching over 50,000 people a month.
Click here now to get started.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.